1.Measurement and clinical significance of serum LDH,MCP-1,and TCF4 in patients with cerebral small vessel disease complicated by depression
Journal of Apoplexy and Nervous Diseases 2026;43(1):47-51
Objective To explore the changes in serum lactate dehydrogenase (LDH), monocyte chemoattractant protein-1 (MCP-1), and transcription factor 4 (TCF4) levels in patients with cerebral small vessel disease complicated by depression and their clinical significance. Methods According to the inclusion and exclusion criteria, 90 patients admitted to the Kailuan General Hospital between January 2022 and August 2024 were selected as the study subjects, including 27 patients diagnosed with cerebral small vessel disease complicated by depression and 63 patients with cerebral small vessel disease uncomplicated by depression. An additional 45 healthy individuals with normal head MRI findings and no mental disorders during the same period at the hospital were selected as the control group. General information was collected from the three groups, including age, body mass index, systolic blood pressure, and diastolic blood pressure.The general information and the levels of serum LDH,MCP-1,and TCF4 in the three groups were compared. The correlations of serum LDH,MCP-1,and TCF4 levels with HAMD score in patients with cerebral small vessel disease and depression were analyzed. Logistic regression was applied to analyze possible factors leading to depression in patients with cerebral small vessel disease.The receiver operating characteristic curve was applied to analyze the efficacy of serum LDH, MCP-1, and TCF4 levels in diagnosing depression in patients with cerebral small vessel disease. Results The levels of serum LDH, MCP-1,and TCF4 were significantly higher in the cerebral small vessel disease complicated by depression group than in cerebral small vessel disease uncomplicated with depression group and the control group (P<0.05), and these levels were significantly higher in the cerebral small vessel disease uncomplicated with depression group than in the control group (P<0.05).The serum LDH,MCP-1 and TCF4 were positively correlated with HAMD score in patients with cerebral small vessel disease complicated with depression(r=0.606,0.798,0.672,all P<0.001).Serum LDH, MCP-1, and TCF4 were influencing factors for depression in cerebral small vessel disease(P<0.05).The area under the receiver operating characteristic curve of LDH, MCP-1,and TCF4 in combination in the diagnosis of depression in cerebral small vessel disease was 0.917, which was superior to serum LDH, MCP-1, and TCF4 alone (ZLDH-combination=2.457,P=0.014;ZMCP-1-combination=2.384, P=0.017; ZTCF4-combination=2.317, P=0.021). Conclusion Serum LDH, MCP-1, and TCF4 levels increased in patients with cerebral small vessel disease complicated with depression. Their combination is valuable in the diagnosis of cerebral small vessel disease complicated with depression.
Depression
2.The development trajectory of sleep disturbance in patients with hepatolenticular degeneration and its relationship with depression:A cross-lagged regression analysis
Journal of Apoplexy and Nervous Diseases 2026;43(2):131-134
Objective To investigate the changing trend of sleep disturbance in patients with hepatolenticular degeneration and the bidirectional relationship between sleep disturbance and depression through a cross-lagged regression analysis. Methods A total of 80 patients who met the diagnostic criteria for WD from January to June 2024 were enrolled in this longitudinal study and were followed up for 3 months.Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality, and Beck Depression Inventory (BDI) was used to assess the severity of depression, at the time of enrollment (T0), at 1 month after enrollment (T1),and at 2 months after enrollment (T3). An unconditional growth model was used to analyze the trajectory of sleep disturbance, and a cross-lagged regression model was used to investigate the temporal relationship between sleep disturbance and depression. Results From T0 to T2, there were significant increases in PSQI and BDI scores in all WD patients(P<0.05). The variance of the intercept factor (the initial status of sleep disturbance) was estimated at 10.83(P<0.01),and the variance of the slope factor (the rate of change in sleep disturbance) was 1.20 (P<0.01),with a significant negative correlation between the intercept and the slope (r=-0.25,P<0.01). The correlation analysis of PSQI and BDI scores across the three time points revealed a positive correlation between PSQI and BDI scores (r∈[0.19,0.96],P<0.01).The cross-lagged model analysis showed that sleep disturbance significantly predicted subsequent depression (P<0.01),with standardized regression coefficients (β) of 0.392 and 0.347, respectively; meanwhile, depression also significantly predicted subsequent sleep disturbance (P<0.01), with β of 0.273 and 0.372, respectively. These findings suggested a bidirectional predictive relationship between sleep disturbance and depression in WD patients over time. Conclusion There is a bidirectional relationship between sleep disturbance and depression in patients with WD, and depression has a more pronounced influence on sleep disturbance. Therefore, clinical interventions should focus on both sleep and psychological state, and combined management should be performed to improve the effect of disease control.
Depression
3.Causal relationship between Parkinson disease and the risk of mental illness: A two-sample Mendelian randomization study
Journal of Apoplexy and Nervous Diseases 2026;43(2):145-149
Objective Observational studies have shown an association between Parkinson disease (PD) and mental illness, but further studies are needed to explore the causal relationship between them. This study aims to investigate such causal relationship using the method of two-sample Mendelian randomization (MR). Methods Related data were extracted from GWAS, and summary statistics associated with PD, depression, sleep disorders, and anxiety phenotype-variants were obtained. Single nucleotide polymorphisms (SNPs) for PD were selected as instrumental variables, and MR-PRESSO was used to exclude outliers. Inverse variance weighting was used as the main method to assess causal effect estimates, and MR Egger, weighted median, simple mode, and weighted mode were used to verify the robustness of the findings. A sensitivity analysis was used to validate the reliability of the results, including the Cochran Q test, the MR-Egger intercept test, funnel plots, and the leave-one-out method. Results A total of 21 SNPs associated with PD were identified. The MR analysis showed that PD had a causal relationship with depression (OR=0.974,95%CI 0.934‒1.015, P=0.210), sleep disorders (OR=1.056, 95%CI 0.970-1.149, P=0.211), and anxiety (OR=0.998, 95%CI 0.996‒1.001, P=0.118), with no statistical significance. Different MR analyses and sensitivity analyses showed that PD did not directly contribute to the development of mental illness. Conclusion There is no direct causal relationship between PD and depression/sleep disorders/anxiety. In clinical practice, healthcare professionals should pay attention to the mental health of patients with PD. Randomized controlled studies should be conducted in the future to further validate the results of this study.
Depression
;
Anxiety
4.Anxiety and depression among pregnant women subjected to ultrasonographic detection of structural fetal anomalies in a public tertiary hospital
Sharon Jane Pingol Galagnara ; Valerie Tiempo-Guinto ; Christi Annah Valmores Hipona
Philippine Journal of Obstetrics and Gynecology 2025;49(1):50-61
BACKGROUND
Anxiety and depression are prevalent during pregnancy. There is significant evidence that antenatal anxiety and depression are risk factors for adverse maternal and neonatal outcomes.
OBJECTIVEThis study aims to determine the prevalence of anxiety and depression among pregnant women who undergo ultrasonographic detection of structural fetal anomalies in the Department of Maternal and Fetal Medicine of University of the Philippines–Philippine General Hospital, Manila, Philippines, for a 13-month period.
METHODSThe study utilized a comparative cross-sectional study design comparing those who underwent congenital anomaly scan (CAS) with those who just underwent routine biometry. There were 177 research respondents for each group. The Filipino version of the Hospital Anxiety and Depression Scale (HADS-P) was used. The psychiatric interview was based on the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM V) particularly on the Major Depressive DIsorder and the Generalized Anxiety Disorder.
RESULTSThe results showed that the mean pre-diagnostics anxiety score of women who underwent CAS was significantly higher than the mean pre-diagnostics anxiety score of women who had biometry. The mean post-diagnostics depression score of women who underwent CAS was significantly higher than the mean post-diagnostics depression score of women who had biometry. However, all pregnant women had normal HADS-P score before and after CAS and biometry. Psychiatric evaluation showed that none was diagnosed to have generalized anxiety disorder or major depression in the conduct of the diagnostic tests.
CONCLUSIONThis study indicates that generalized anxiety and depression among pregnant patients subjected to routine biometry and congenital scan were not problems in this tertiary hospital. Knowledge of CAS and awareness of risk factors for congenital anomalies are important for providing care and counseling pregnant women.
Human ; Anxiety ; Depression
5.Xiaoyao Pill Regulates Gut Microbiota and Tryptophan Metabolism to Alleviate Depression Induced by Chronic Stress in Rats.
Ying LIU ; Jie SHEN ; Xing ZHANG ; Fan PING ; Kai QYU ; Xia SHEN
Chinese journal of integrative medicine 2025;31(12):1087-1096
OBJECTIVE:
To investigate the antidepressant effects of Xiaoyao Pill (XYP) by exploring its interactions with gut microbiota and tryptophan metabolism.
METHODS:
Utilizing network pharmacology, the functional substance groups, key targets, and pathways of XYP in the treatment of depression were identified. The chronic unpredictable mild stress (CUMS) protocol was implemented in male Sprague-Dawley rats to establish depression model. Thirty rats were randomly divided into 3 groups according to their body weight (10 for each): control, CUMS and XYP groups (1.8 g/kg). After 28-day interventions, behavioral phenotyping including sucrose preference test (SPT) and open field test (OFT) were performed. Biochemical validation encompassed enzyme-linked immunosorbent assay for serum cortisol, hematoxylin-eosin histopathology, and immunohistochemistry. Liquid chromatography-mass spectrometry was utilized to profile serum metabolites, while fecal samples underwent metagenomic sequencing for gut microbiota characterization.
RESULTS:
Network pharmacology studies predicted that key components can protect the nervous system by regulating inflammatory pathways through the blood-brain barrier. SPT and OFT showed that XYP treatment significantly ameliorated depressive-like behaviors (all P<0.05). XYP treatment also restored hippocampal neuronal density, increased serum neurotransmitter levels of neurotransmitters such as 5-hydroxytryptamine and vasoactive intestinal peptide, and while suppressing inflammatory markers such as tumor necrosis factor-alpha, interleukin-1 beta (IL-1 β), and IL-6 (all P<0.05). Metagenomics revealed significant restructuring of gut microbiota, notably the regulation of Parabacteroides distasonis (P<0.05). Non-targeted metabolomics analysis showed that the level of metabolites in the tryptophan and kynurenine pathway significantly changed (variable importance in the projection >1, P<0.05), and the change of metabolic flux was significantly correlated with behavioral improvement (P<0.05).
CONCLUSIONS
XYP exerts antidepressant effects by increasing neurotransmitter levels, reducing inflammatory makers and modulating Parabacteroides distasonis. Through further exploration of metabolomics, we found that XYP may play a protective role in depression by regulating tryptophan metabolism.
Animals
;
Tryptophan/metabolism*
;
Drugs, Chinese Herbal/therapeutic use*
;
Gastrointestinal Microbiome/drug effects*
;
Rats, Sprague-Dawley
;
Depression/blood*
;
Male
;
Stress, Psychological/drug therapy*
;
Behavior, Animal/drug effects*
;
Rats
;
Chronic Disease
;
Hippocampus/drug effects*
6.Suanzaoren Decoction Alleviates Anxiety- and Depression-Like Behaviors Induced by Chronic Restraint Stress via Regulating Pyramidal Neuron Activity in Basolateral Amygdala of Mice.
Chang-Feng CHEN ; Yin-Huan GAO ; Qin FANG ; Yong-Feng ZHOU ; Yong LIU ; Jian WU ; Hao CHEN ; Lie-Cheng WANG ; Lei CHEN
Chinese journal of integrative medicine 2025;31(11):982-990
OBJECTIVE:
To elucidate the modulation mechanism of Suanzaoren Decoction (SZRD) on basolateral amygdala (BLA) neuronal activity to alleviate chronic restraint stress (CRS)-related behavioral deficits.
METHODS:
The male C57BL/6J mice were assigned to 4 groups using the complete randomization method, including control (CON, n=19), CRS (n=19), SZRD (n=21), and fluoxetine (Flu, n=22) groups. Mice were restrained for 6 h per day, over a 21-d period to establish CRS models. The CON group remained in their cages without food or water during the 6-h matching period. SZRD and Flu groups received intragastric administration of SZRD (4.68 g/kg) and Flu (20 mg/kg) daily, respectively, 30 min before restraint for 21 consecutive days. The therapeutic effects of SZRD were evaluated using behavioral tests including the tail suspension test, elevated plus maze test, and forced swimming test. The cellular Fletcher B. Judson murine osteosarcoma proto-oncogene (c-Fos) expression in the BLA was measured using immunofluorescence, while action potential (AP) firing and synaptic transmission in BLA pyramidal neurons were evaluated using whole-cell patch-clamp recordings.
RESULTS:
SZRD administration significantly increased time spent in the open arms and open-arm entries while reducing immobility time (P<0.05 or P<0.01). It downregulated CRS-induced c-Fos expression and AP firing of pyramidal neurons in the BLA (P<0.01). Additionally, SZRD selectively attenuated excitatory (P<0.01), but not inhibitory, synaptic transmission onto BLA pyramidal neurons.
CONCLUSION
SZRD alleviated CRS-induced anxiety- and depression-like behaviors in mice by modulating the excitability and synaptic transmission of BLA pyramidal neurons.
Animals
;
Drugs, Chinese Herbal/therapeutic use*
;
Depression/complications*
;
Pyramidal Cells/pathology*
;
Male
;
Mice, Inbred C57BL
;
Basolateral Nuclear Complex/pathology*
;
Restraint, Physical
;
Anxiety/complications*
;
Behavior, Animal/drug effects*
;
Stress, Psychological/physiopathology*
;
Mice
;
Proto-Oncogene Proteins c-fos/metabolism*
;
Action Potentials/drug effects*
;
Synaptic Transmission/drug effects*
7.Impact of future-oriented coping on depression among medical staff: A chain mediation model involving psychological resilience and perceived stress.
Minghui LIU ; Xinyu CHEN ; Qing LU ; Daifeng DONG ; Yi ZHANG ; Muli HU ; Na YAO
Journal of Central South University(Medical Sciences) 2025;50(2):281-289
OBJECTIVES:
Depression is a common negative emotion that can significantly impact physical and mental health. Due to their occupational characteristics, medical staff are more susceptible to depression compared to the general population. This study aims to explore the influence of future-oriented coping on depression among medical staff and the mediating roles of psychological resilience and perceived stress, providing theoretical guidance for depression intervention strategies in this group.
METHODS:
A cross-sectional survey was conducted among medical staff at a tertiary hospital using convenience sampling. Data were collected via the "Wenjuanxing" platform. A total of 754 questionnaires were distributed; after excluding invalid responses (e.g., duplicate IPs or insufficient completion time), 655 valid questionnaires were retained (valid response rate: 86.87%). Instruments included a demographic questionnaire, the Future-Oriented Coping Scale, the Connor-Davidson Resilience Scale, the Perceived Stress Scale, and the Self-Rating Depression Scale. All scales demonstrated high internal consistency (Cronbach's α>0.88) and validity. SPSS 27.0 was used for descriptive analysis, and PROCESS macro (Model 6) was used to test the chain mediation model. Harman's one-factor test was applied to control for common method bias.
RESULTS:
Descriptive analyses showed that future-oriented coping was positively correlated with psychological resilience and negatively correlated with perceived stress and depression. Mediation analysis revealed that future-oriented coping significantly predicted lower depression levels among medical staff (β=-0.283, P<0.001). Psychological resilience partially mediated the relationship (effect size=-0.329, accounting for 34.13% of the total effect), as did perceived stress (effect size=-0.099, 10.27%). A significant chain mediation path was identified: "future-oriented coping → psychological resilience → perceived stress → depression" (effect size=-0.253, 26.24%). The total indirect effect accounted for 70.64% of the overall effect, highlighting the substantial role of the mediating pathways.
CONCLUSIONS
Future-oriented coping can reduce depressive symptoms in medical staff, with psychological resilience and perceived stress serving as key mediators in a chain structure. These findings suggest that enhancing future-oriented coping strategies and psychological resilience may improve stress adaptation and reduce depression levels in this population.
Humans
;
Adaptation, Psychological
;
Resilience, Psychological
;
Cross-Sectional Studies
;
Depression/psychology*
;
Surveys and Questionnaires
;
Stress, Psychological/psychology*
;
Male
;
Female
;
Adult
;
Middle Aged
;
Medical Staff/psychology*
;
Occupational Stress/psychology*
8.Association between stigma and quality of life in community-dwelling patients with schizophrenia: Multiple mediating roles of anxiety and depression symptoms.
Yue CHEN ; Xiaoyan WAN ; Qin YANG ; Changjiu HE ; Xuanyi HU ; Xiang LIU ; Yuanyuan LIU
Journal of Central South University(Medical Sciences) 2025;50(6):1042-1051
OBJECTIVES:
Stigma is common among community-dwelling patients with schizophrenia and has a profound negative impact on both psychiatric symptoms and quality of life. This study aims to explore the association between stigma and quality of life in this population and to examine the multiple mediating roles of anxiety and depression symptoms.
METHODS:
The multi-stage stratified cluster random sampling method was used to select the community-dwelling patients with schizophrenics in Chengdu, Sichuan Province, China. The questionnaire included general demographic characteristics, stigma question, the Generalized Anxiety Disorder-7 (GAD-7) scale, the Patient Health Questionnaire-9 (PHQ-9), and the 12-item Short Form Health Survey (SF-12). The SF-12 was used to measure quality of life, including physical health and mental health dimensions. A multiple mediation model was used to analyse the mediating effects of anxiety and depression symptoms together between stigma and quality of life.
RESULTS:
A total of 1 087 community patients with schizophrenia were included with a mean age of 50.68±12.73 years; 525 (48.30%) were male. Stigma was reported by 543 patients (49.95%). Anxiety symptoms were present in 292 patients (26.86%), and depression symptoms in 407 patients (37.44%). The physical health quality of life score was 72.01 ± 20.99, and the mental health quality of life score was 71.68 ± 19.38. Multiple mediation analysis showed that stigma directly affected quality of life, and also indirectly affected quality of life through anxiety and depression symptoms. Anxiety and depression jointly mediated 42.26% of the total effect of stigma on physical health quality of life and 47.51% on mental health quality of life.
CONCLUSIONS
Reducing stigma and preventing anxiety and depression symptoms in community-dwelling patients with schizophrenia can effectively improve their quality of life and support reintegration into society.
Humans
;
Quality of Life
;
Male
;
Depression/psychology*
;
Middle Aged
;
Social Stigma
;
Schizophrenia
;
Female
;
Anxiety/psychology*
;
China
;
Surveys and Questionnaires
;
Adult
;
Schizophrenic Psychology
;
Independent Living
;
Aged
9.Potential biological mechanisms underlying spaceflight-induced depression symptoms in astronauts.
Zejun LI ; Jin LIU ; Bangshan LIU ; Mi WANG ; Yumeng JU ; Yan ZHANG
Journal of Central South University(Medical Sciences) 2025;50(8):1355-1362
Long-term spaceflight exposes astronauts to multiple extreme environmental factors, such as cosmic radiation, microgravity, social isolation, and circadian rhythm disruption, that markedly increase the risk of depressive symptoms, posing a direct threat to mental health and mission safety. However, the underlying biological mechanisms remain complex and incompletely understood. The potential mechanisms of spaceflight-induced depressive symptoms involve multiple domains, including alterations in brain structure and function, dysregulation of neurotransmitters and neurotrophic factors, oxidative stress, neuroinflammation, neuroendocrine system imbalance, and gut microbiota disturbances. Collectively, these changes may constitute the biological foundation of depressive in astronauts during spaceflight. Space-related stressors may increase the risk of depressive symptoms through several pathways: impairing hippocampal neuroplasticity, suppressing dopaminergic and serotonergic system function, reducing neurotrophic factor expression, triggering oxidative stress and inflammatory responses, activating the hypothalamic-pituitary-adrenal axis, and disrupting gut microbiota homeostasis. Future research should integrate advanced technologies such as brain-computer interfaces to develop individualized monitoring and intervention strategies, enabling real-time detection and effective prevention of depressive symptoms to safeguard astronauts' psychological well-being and mission safety.
Space Flight
;
Humans
;
Astronauts/psychology*
;
Depression/physiopathology*
;
Gastrointestinal Microbiome
;
Weightlessness/adverse effects*
;
Oxidative Stress
;
Brain/physiopathology*
;
Hypothalamo-Hypophyseal System
;
Neuronal Plasticity
;
Pituitary-Adrenal System
10.A cross-sectional study on healthy lifestyle and the risk of anxiety and depression among adults undergoing health examinations.
Yangyiyi YU ; Jiale LIU ; Pu PENG ; Ting YUAN ; Jinrong ZENG ; Jianyun LU
Journal of Central South University(Medical Sciences) 2025;50(8):1428-1442
OBJECTIVES:
Depressive and anxiety disorders are among the most common mental disorders worldwide and are associated with unhealthy lifestyle behaviors. The Life's Simple 7 (LS7) guideline proposed by the American Heart Association aims to reduce cardiovascular risk by improving behaviors such as diet and physical activity, but its impact on mental health is not yet fully clear. This study examined the association between LS7 scores and symptoms of anxiety and depression in adults undergoing routine health examinations.
METHODS:
Data were collected from individuals who underwent health examinations from May 2015 to December 2024 at the Health Management Center of the Third Xiangya Hospital. All participants completed the LS7 assessments, the Self-Rating Depression Scale (SDS), and the Self-Rating Anxiety Scale (SAS). Participants were categorized into 4 LS7 score groups: Low (≤7), average (8-9), good (10), and excellent (11-14). Those with SDS or SAS≥50 were classified as having mental disorder symptoms; with this group, SAS≥50 indicated anxiety, SDS≥50 indicated depression, and SDS and SAS≥50 indicated comorbid anxiety-depression. Binary logistic regression was used to assess associations between LS7 score and mental symptoms, calculating odds ratio (OR) and 95% confidence interval (CI). A restricted cubic spline (RCS) regression model was used to analyze the dose-response relationship between LS7 score (continuous variable) and the risk of mental symptoms. Nodes were set at the 5th, 35th, 65th, and 95th percentiles of the LS7 score, with the 5th percentile as the reference point. All models were adjusted for covariates such as gender, age, living alone, drinking status, education level, and sleep quality. Logistic regression framework was used to fit and calculate the adjusted OR (aOR) and 95% CI. Nonlinear relationship tests were also conducted. Subgroup analysis was performed to explore the interaction between gender, age, drinking habits, education level, and other factors and the LS7 score in influencing the risk of mental symptoms.
RESULTS:
A total of 5 449 participants were included; 1 363 (25.01%) had depressive symptoms, 398 (7.30%) had anxiety symptoms, and 259 (4.75%) had comorbid anxiety-depression. The prevalence of mental symptoms decreased significantly as LS7 scores increased. Univariate and multivariate Logistic regression indicated that LS7 score≥8 was protective against mental symptoms. Multivariate Logistic regression demonstrated moderate discriminative ability (AUC=0.672). Among individuals with anxiety, depression, or comorbid symptoms, LS7 score distributions showed a graded decrease from poor to excellent groups. After adjustment, an excellent LS7 score was associated with a 39% lower risk of depression (aOR=0.61, 95% CI 0.47 to 0.78, P<0.001), a 63% lower risk of anxiety (aOR=0.37, 95% CI 0.22 to 0.59, P<0.001), and a 66% lower risk of comorbid anxiety-depression (aOR=0.34, 95% CI 0.17 to 0.62, P=0.001). The AUC values of the anxiety model, depression model, and comorbid anxiety and depression model were 0.632, 0.672, and 0.619, respectively. All models demonstrated moderate discriminatory ability, which was statistically significant, but their capacity to distinguish cases from non-cases was limited. RCS analysis confirmed a linear inverse relationship between LS7 score and mental symptom risk. Not smoking and regular physical activity were the strongest protective behaviors. Subgroup analysis suggested stronger protective effects in men, younger adults (≤60), non-drinkers, and those with higher education levels, and revealed a significant interaction between alcohol use and LS7 score (P for interaction=0.021), indicating that alcohol consumption may weaken the protective effect of LS7.
CONCLUSIONS
Ideal healthy lifestyle behaviors, as reflected by higher LS7 scores, are associated with lower risks of anxiety and depression in adults. Promoting LS7-based lifestyle practices may serve as a practical and effective strategy for the prevention and management of anxiety and depression in both clinical and daily life settings.
Humans
;
Cross-Sectional Studies
;
Depression/epidemiology*
;
Anxiety/epidemiology*
;
Adult
;
Male
;
Female
;
Middle Aged
;
Healthy Lifestyle
;
Risk Factors
;
Anxiety Disorders/epidemiology*
;
Exercise
;
Physical Examination
;
Aged


Result Analysis
Print
Save
E-mail